Literature DB >> 21225080

Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents.

Flora L Thorp-Greenwood1, Michael P Coogan.   

Abstract

This perspective focuses on complexes of radioactive metal ions applied in multimodal radio- and optical imaging. The application of metal ions in radioimaging techniques such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) has advantages over lighter nuclei in terms of half-life, but there are particular issues related to their speciation (particularly leaching from complexes) and with the combination of certain ions with fluorescent systems. The basic coordination chemistry of the ions involved and issues relating to biological conditions and their compatibility with optical imaging techniques are reviewed, the current literature presented in context, and the prospect of exploiting the intrinsic luminescence of certain metal-ligand complexes is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225080     DOI: 10.1039/c0dt01398f

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  13 in total

Review 1.  Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke
Journal:  Chem Soc Rev       Date:  2011-05-23       Impact factor: 54.564

Review 2.  Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence.

Authors:  Patrick T K Chin; Mick M Welling; Stefan C J Meskers; Renato A Valdes Olmos; Hans Tanke; Fijs W B van Leeuwen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-15       Impact factor: 9.236

3.  Organometallic rhenium tricarbonyl-enrofloxacin and -levofloxacin complexes: synthesis, albumin-binding, DNA-interaction and cell viability studies.

Authors:  Chaido-Christina Pagoni; Vasiliki-Styliani Xylouri; Georgios C Kaiafas; Marialena Lazou; Georgia Bompola; Evangelos Tsoukas; Lefkothea C Papadopoulou; George Psomas; Dionysia Papagiannopoulou
Journal:  J Biol Inorg Chem       Date:  2019-05-20       Impact factor: 3.358

Review 4.  Recent development of nanoparticles for molecular imaging.

Authors:  Jonghoon Kim; Nohyun Lee; Taeghwan Hyeon
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2017-11-28       Impact factor: 4.226

5.  Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression.

Authors:  Joeri Kuil; Tessa Buckle; Joppe Oldenburg; Hushan Yuan; Alexander D Borowsky; Lee Josephson; Fijs W B van Leeuwen
Journal:  Mol Pharm       Date:  2011-11-15       Impact factor: 4.939

Review 6.  Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.

Authors:  David G Calatayud; Sotia Neophytou; Eleni Nicodemou; S Giuseppe Giuffrida; Haobo Ge; Sofia I Pascu
Journal:  Front Chem       Date:  2022-04-12       Impact factor: 5.545

7.  Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119

Authors:  Parmissa Randhawa; Aeli P Olson; Shaohuang Chen; Kaley Lexi Gower-Fry; Cornelia Hoehr; Jonathan W Engle; Caterina F Ramogida; Valery Radchenko
Journal:  Curr Radiopharm       Date:  2021

8.  A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy.

Authors:  Antoine Maruani; Mark E B Smith; Enrique Miranda; Kerry A Chester; Vijay Chudasama; Stephen Caddick
Journal:  Nat Commun       Date:  2015-03-31       Impact factor: 14.919

9.  Hybrid Hierarchical Heterostructures of Nanoceramic Phosphors as Imaging Agents for Multiplexing and Living Cancer Cells Translocation.

Authors:  David G Calatayud; Teresa Jardiel; Mara S Bernardo; Vincenzo Mirabello; Haobo Ge; Rory L Arrowsmith; Fernando Cortezon-Tamarit; Lorena Alcaraz; Josefa Isasi; Pablo Arévalo; Amador C Caballero; Sofia I Pascu; Marco Peiteado
Journal:  ACS Appl Bio Mater       Date:  2021-03-10

10.  In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA5.SA.FAPi and DOTA.SA.FAPi.

Authors:  Euy Sung Moon; Yentl Van Rymenant; Sandeep Battan; Joni De Loose; An Bracke; Pieter Van der Veken; Ingrid De Meester; Frank Rösch
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.